In the latest quarter, 6 analysts provided ratings for BioNTech (NASDAQ:BNTX), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of BioNTech SE (Symbol: BNTX) entered into oversold territory, hitting an RSI reading of 29.3 ...

Deep-pocketed investors have adopted a bearish approach towards BioNTech (NASDAQ:BNTX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...

European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 B1 and maintains the patent in amended form Confirming validity of ...

Vaccine stocks have been under significant pressure in recent days following news that the FDA director who oversaw the ...

We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

Mitsubishi UFJ Asset Management Co. Ltd. reduced its stake in BioNTech SE (NASDAQ:BNTX – Free Report) by 20.0% in the 4th ...

BioNTech (NASDAQ:BNTX – Get Free Report) had its target price dropped by analysts at HC Wainwright from $150.00 to $145.00 in ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

BioNTech SE (NASDAQ:BNTX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eighteen brokerages that are covering the company, MarketBeat.com reports. Three research ...

Pfizer (NYSE:PFE) shares reached a session low on Wednesday after The Wall Street Journal reported that the U.S. attorney’s ...